ACTUALITÉS ET ÉVÉNEMENTS
Learn about the strategic partnership between Aramis Biotechnologies and Biodextris to advance vaccine and biologics development.
Biodextris inaugurates its new Laval facility in Biotech City, expanding its capabilities in biologics development and manufacturing.
Discover Biodextris' new cGMP biomanufacturing and analytical facility. Check out our state-of-the-art capabilities.
Discover how Quality by Design (QbD) helps streamline biologics development, reduce costs, and improve product outcomes in complex CDMO environments.
Explore how a project-based CDMO collaboration model ensures better flexibility, transparency, and outcomes in biologics development.
Biodextris and Calder Biosciences partner for a Phase 1 RSV vaccine trial. Read how this collaboration accelerates vaccine innovation.
Biodextris launches a new cGMP facility designed for advanced biomanufacturing and analytical services. See what this means for your next project.
Explore whether cell culture is replacing microbial fermentation in biologics manufacturing—and what this shift means for CDMO strategy and innovation.
Why is process development so complex and time-consuming in biologics? Get insights into key challenges and solutions for accelerating timelines.